Development of Dihydropyridone Indazole Amides as Selective Rho-Kinase Inhibitors Haifeng Cui, Sarah E. Dowdell,et al. J. Med. Chem 2007;50:6-9
Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson’s disease R. Jeremy NICHOLS,Nicolas DZAMKO,et al. Biochem. J 2009;424:47–60
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.